Velit Biologics

Velit Biologics Velit Biologics is developing SB101 which is a novel, promising drug that can improve the performance of cancer therapy.

Velit Biologics develops SB101, a novel compound which starves tumors by cutting off their blood supply. Our medicine has proven effective in animal studies on several cancer types that today lack treatments. Furthermore, SB101 acts through a new, specific mechanism which means that the medicine can be used on resistant tumors when other drugs fail.

13/06/2012

Another interview. This time Alexander takes the centre stage and shares our feelings after the jury meeting. http://bambuser.com/v/2742195

Broadcast by venturecupvast on Bambuser.com

We finished at third place in the regional final yesterday and won 50 000 SEK. =) Thanks a lot for the support! And cong...
11/05/2012

We finished at third place in the regional final yesterday and won 50 000 SEK. =) Thanks a lot for the support! And congrats Cyto365 for winning the competition!

http://www.gp.se/ekonomi/1.940035-basta-affarsplanen-i-vast

Micael Törnblom såg sin flickvän behandlas med cellgift mot bröstcancer. Då konstruerade han en droppventil som hindrar blodpropp.

07/05/2012

We just finished our 10min pitch to the Venture Cup jury. Wish us luck!

03/05/2012

Adress

Medicinaregatan 8
Gothenburg
41390

Telefon

+46317728051

Webbplats

Aviseringar

Var den första att veta och låt oss skicka ett mail när Velit Biologics postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Genvägar

Dela

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram